APA (7th ed.) Citation

Wright, A. K., Carr, M. J., Kontopantelis, E., Leelarathna, L., Thabit, H., Emsley, R., . . . Rutter, M. K. (2022). Primary Prevention of Cardiovascular and Heart Failure Events With SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Their Combination in Type 2 Diabetes. Diabetes care, 45(4), 909-918. https://doi.org/10.2337/dc21-1113

Chicago Style (17th ed.) Citation

Wright, Alison K., et al. "Primary Prevention of Cardiovascular and Heart Failure Events With SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Their Combination in Type 2 Diabetes." Diabetes Care 45, no. 4 (2022): 909-918. https://doi.org/10.2337/dc21-1113.

MLA (9th ed.) Citation

Wright, Alison K., et al. "Primary Prevention of Cardiovascular and Heart Failure Events With SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Their Combination in Type 2 Diabetes." Diabetes Care, vol. 45, no. 4, 2022, pp. 909-918, https://doi.org/10.2337/dc21-1113.